Ariceum Therapeutics and NorthStar Medical Radioisotopes Announce Supply Agreement for Therapeutic Radioisotope Actinium-225

Ariceum Therapeutics United States of America United Kingdom Germany New York Wisconsin

NorthStar will supply non-carrier added Actinium-225, a radionuclide, for use with Ariceum's first-in-class radiopharmaceutical drug, satoreotideView original content:https://www.prnewswire.co.uk/news-releases/ariceum-therapeutics-and-northstar-medical-radioisotopes-announce-supply-agreement-for-therapeutic-radioisotope-actinium-225-302328007.html